Vessi Medical Reaps $1.7 Million in Funding for Minimally Invasive Bladder Cancer Treatment

MISGAV, Israel, Aug. 31, 2020 -- (Healthcare Sales & Marketing Network) -- Vessi Medical, a portfolio company of The Trendlines Group Ltd. (SGX: 42T) (OTCQX: TRNLY) announced that it secured $1.7 million in funding for its cryoablation solution for superf... Devices, Urology, Oncology, Venture Capital Vessi Medical, cryoablation, cryo-spray ablation
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news